Sugammadex Injection, Solution
Product Images NDC 70710-1650

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 70710-1650). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 01)

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 02)

FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 03)

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 03)
This text provides data on recovery times for patients given sugammadex and neostigmine for reversal of neuromuscular blockade. It includes median recovery times and quartiles (Q1, Q3) as well as the dosages administered. Censored observations are also noted in the analysis.*
FDA Label Image

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 04)

Image (75ac6da6 477a 483f Aced F266e2e8c2a9 04)
This is a comparison of Cumulative Recovery Rate using Sugammadex and Neostigmine based on time to recovery in minutes. Sugammadex has a faster recovery time of 2.1 minutes compared to Neostigmine's 200 minutes. The graph shows the distribution of recovery times for the two medications. The study includes a group of 38 patients with Vecuronium plus Sugammadex and 35 patients with Vecuronium plus Neostigmine. Medians and quartiles (Q1, Q3) are provided based on product-fit estimates.*
FDA Label Image

2ml Vial (75ac6da6 477a 483f Aced F266e2e8c2a9 05)

FDA Label Image

5ml Vial (75ac6da6 477a 483f Aced F266e2e8c2a9 06)

5ml Vial (75ac6da6 477a 483f Aced F266e2e8c2a9 06)
This text provides important information about a medication called Sugammadex, which is intended for intravenous use only. It is available in a 500 mg/5 mL strength and is stored at 25°C. The medication should be protected from light and is supplied in a 5mL single-dose vial. The dosage details and storage instructions are provided for healthcare professionals. It is distributed by Zydus Pharmaceuticals (USA) Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.